ABIO Insider Trading Activity and SEC Form 4 Filings
ABIO insider trading summary
No open-market insider purchases or sales of ARCA biopharma, Inc. (ABIO) have been reported on SEC Form 4 in the past 12 months.
Latest ABIO insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Aug 16, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $16K (5,390 @ $2.93) |
| Aug 16, 2024 | Janus Henderson Biotech Innovation Master Fund Ltd | 10% Owner | Buy | $16K (5,390 @ $2.93) |
| Aug 16, 2024 | Janus Henderson Biotech Innovation Master Fund Ltd | 10% Owner | Buy | $1K (428 @ $2.98) |
| Aug 16, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $1K (428 @ $2.98) |
| Jul 25, 2024 | Janus Henderson Biotech Innovation Master Fund Ltd | 10% Owner | Buy | $92K (30,227 @ $3.05) |
| Jul 25, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $92K (30,227 @ $3.05) |
| Jul 24, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $57K (17,800 @ $3.18) |
| Jul 24, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $22K (7,056 @ $3.16) |
| Jul 24, 2024 | Janus Henderson Biotech Innovation Master Fund Ltd | 10% Owner | Buy | $22K (7,056 @ $3.16) |
| Jul 24, 2024 | Janus Henderson Group PLC | 10% Owner | Buy | $528K (165,000 @ $3.20) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.